This was done by identifying all TCGA patients whose adult glioma verification depended on their + 7/ − 10 status and settling on the highest threshold for + 7/ − 10 that did not exclude tumors whose age and outcome were consistent with quintessential IDH-wildtype glioblastoma. This evidence concerns the gene IDH1 and central nervous system cancer.